Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

J.H. Lee; Su Yin Lim; Alexander M. Menzies; Matteo S. Carlino; Alexander Guminski; Kazi Nahar; David Palmieri; Edmond J. Breen; Richard Kefford; Richard A Scolyer; Georgina V. Long; Helen Rizos

doi:10.1093/annonc/mdy303.031

Article2021

Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Helen Dearden, Lewis Au, Daniel Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Cuvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies

Article2018

Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy.

Helen Dearden, Lewis Au, Daniel Ying Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Curvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Alexander Guminski, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies

Article2021

Original Research Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Helen Dearden, Lewis Au, Daniel Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Cuvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies

Article2018

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy

Su Yin Lim, Jenny Lee, Tuba N. Gide, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Edmond J. Breen, Jean Yang, Shila Ghazanfar, Richard A Scolyer, Georgina V. Long, Helen Rizos

Preprint2023

Data from Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy

Su Yin Lim, Jenny Lee, Tuba N. Gide, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Edmond J. Breen, Jean Yang, Shila Ghazanfar, Richard F. Kefford, Richard A Scolyer, Georgina V. Long, Helen Rizos

Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

Discussion(0)

Related publications

Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy.

Original Research Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy

Data from Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy